.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Chubb
Moodys
Cipla
Teva
McKesson
Cerilliant
Medtronic
Federal Trade Commission

Generated: December 18, 2017

DrugPatentWatch Database Preview

RESERPINE Drug Profile

« Back to Dashboard

When do Reserpine patents expire, and when can generic versions of Reserpine launch?

Reserpine is a drug marketed by Barr, Bell Pharma, Bundy, Cycle Pharms Ltd, Elkins Sinn, Everylife, Halsey, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Marshall Pharma, Mk Labs, Mylan, Pharmavite, Purepac Pharm, Pvt Form, Rexall, Sandoz, Solvay, Tablicaps, Teva, Valeant Pharm Intl, Watson Labs, Whiteworth Town Plsn, West Ward, Ivax Pharms, Par Pharm, Sun Pharm Industries, and Lederle. and is included in forty-one NDAs.

The generic ingredient in RESERPINE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TevaRESERPINEreserpineTABLET;ORAL089020-001Mar 7, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Pvt FormRESERPINEreserpineTABLET;ORAL086117-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town PlsnRESERPINEreserpineTABLET;ORAL080723-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL085549-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsRESERPINEreserpineTABLET;ORAL080679-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town PlsnRESERPINEreserpineTABLET;ORAL080723-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
West WardRESERPINE AND HYDROCHLOROTHIAZIDE-50hydrochlorothiazide; reserpineTABLET;ORAL088189-001May 10, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsRESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazide; reserpineTABLET;ORAL087556-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanRESERPINEreserpineTABLET;ORAL084974-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pvt FormRESERPINEreserpineTABLET;ORAL080582-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
UBS
US Army
US Department of Justice
Merck
Express Scripts
Medtronic
Julphar
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot